Abstract
Portal vein thrombosis (PVT) is a rare but serious complication in liver cirrhosis. Eltrombopag is a new, second generation agent used for immune thrombocytopenic purpura (ITP). It may cause thrombotic events. PVT has been rarely reported as a life threatening complication in some cirrhotic patients during eltrombopag using. We presented 63 years old cirrhotic and immune thrombocytopenic patient who had PVT after eltrombopag.
Keywords
Additional Information
Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.
Rights and Permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
About This Article
How to Cite This Article
Gül İlhan, Can Acıpayam. Portal vein thrombosis in a chirrotic patient with ımmune thrombocytopenic purpura during eltrombopag treatment. J Clin Anal Med 2016;7(1):35-37. doi:10.4328/JCAM.2540
Publication History
- Received:
- 07.05.2014
- Accepted:
- 01.06.2014
- Published Online:
- 01.01.2016
- Printed:
- 01.01.2016